Protalix BioTherapeutics Inc (PLX)

1.12
0.07 6.67
AMEX : Health Care
Prev Close 1.05
Open 1.04
Day Low/High 1.00 / 1.13
52 Wk Low/High 0.61 / 1.78
Volume 3.06M
Avg Volume 4.13M
Exchange AMEX
Shares Outstanding 123.78M
Market Cap 129.97M
EPS 0.60
P/E Ratio 4.77
Div & Yield N.A. (N.A)

Latest News

Protalix BioTherapeutics Receives Confirmation Of Order For Over $24 Million Of Alfataliglicerase To Treat Gaucher Patients In Brazil

Protalix BioTherapeutics Receives Confirmation Of Order For Over $24 Million Of Alfataliglicerase To Treat Gaucher Patients In Brazil

Shipment Size for Fourth Quarter of 2017 Represents Annual Revenues of approximately $42 Million

Alfataliglicerase Approved For Pediatric Indications In Brazil For The Treatment Of Gaucher Disease In Children Four Years And Older

Alfataliglicerase Approved For Pediatric Indications In Brazil For The Treatment Of Gaucher Disease In Children Four Years And Older

Approval further supports the advanced ongoing discussions with the Brazilian Ministry of Health for the supply of a significant amount of alfataliglicerase for Gaucher patients in Brazil

Protalix BioTherapeutics Doses First Patient In Global Phase III Clinical Trial Of PRX-102 For The Treatment Of Fabry Disease

Protalix BioTherapeutics Doses First Patient In Global Phase III Clinical Trial Of PRX-102 For The Treatment Of Fabry Disease

Six Sites Activated Across the United States and Europe with additional patients currently in the screening process for potential inclusion in trial

IIROC Trading Resumption - PLX

IIROC Trading Resumption - PLX

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering big breakout trades.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.